Thus, BET-i appears to influence the maintenance of polyfunctional progenitor CD4+ and CD8+ T cells in CLL, and it will be important to tease out specific effects of BET-i on Th subsets. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.